Heterologous versus homologous triple anti-COVID-19 vaccine regimens in patients on maintenance haemodialysis.

Björn K MeijersAnnelien GoedgezelschapDomien PeetersAnnelien Van Der VeenMargo VerbinnenPieter VermeerschKoen StasDirk Kuypers

Published in: Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association (2022)

Keyphrases

end stage renal disease
chronic kidney disease
peritoneal dialysis
coronavirus disease
newly diagnosed
sars cov
ejection fraction
prognostic factors
dna damage
dna repair
patient reported outcomes
saccharomyces cerevisiae